Related content

Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer

By Riedel Richard F   Febbo Phillip G  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 461-466

Future Medicine

Access to resources Recommend Favorite

Simple method to detect important epidermal growth factor receptor gene mutations with bronchoscopic specimens of lung cancer patients for gefitinib treatment

By Akagi Kiwamu   Sakai Hiroshi   Sudo Junko   Hommura Yasuo   Kurimoto Futoshi   Komagata Hiroshi   Akiyama Hirohiko   Yoneda Shuichi  

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 145-151

Springer Publishing Company

Access to resources Recommend Favorite

Relative influence of cKit expression and epidermal growth factor receptor gene amplification on survival in patients with nonsmall cell lung cancer

By        

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 582-588

Spandidos Publications

Access to resources Recommend Favorite

Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 329-333

Science Publishers

Access to resources Recommend Favorite

Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer

By Chu Huili   Zhong Chen   Xue Guoliang   Liang Xiuju   Wang Jun   Liu Yingxin   Zhao Shiwei   Zhou Qian   Bi Jingwang  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2311-2315

Spandidos Publications

Access to resources Recommend Favorite